About Conference

Conference Series llc LTD extends its heartfelt welcome to 13^th World Biomarkers Congress that will be held in Dublin, Ireland during November 29-30, 2018. The conference will be organised around the theme "Advances in Biomarker Research''

World Biomarkers 2018 is the premier event that brings together a unique and International mix of experts, researchers and decision makers both from academia and industry across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists, industrialists and entrepreneurs meet.             

World Biomarkers 2018 conference will be organized by Conference Series which is comprised of 3000+ Global Events with over 1000+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse fields of Medical, Pharmaceutical, Clinical, Engineering, Science, Technology and Business World Cancer 2018 deals with study of basic researches in the field of cancer & oncology. It involves identifying causes and to develop strategies for diagnosis, prevention, treatment and cure for this dreadful disease.

We look forward to an exciting 2-day scientific event, business meeting, trade fair and exhibition in the alluring city of Dublin, Ireland.

Why to attend World Biomarkers 2018?

World Biomarkers 2018 is the main event that brings together a unique and international experts, scientists and decision makers both from academia and industry across the world to exchange their knowledge, expertise and research innovations in the arena of cancer treatment. This pinnacle brings together the senior level experts with a perfect blend for multidisciplinary collaboration between innovators, scientists, academicians from all over the world working in the different field of Cancer & Oncology Research.

Scientific Sessions

Track 1: Biomarkers

A biomarker can be anything that can be accurately measured as an indicator of normal biological functioning, pathogenic paths or a drug response to a therapeutic drug intervention.  Biomarkers are usually in molecular form. Biomarkers take part in various purposes, including disease diagnosis and prognosis, prediction and calculation of treatment response, and safety evaluation. The   Biomarkers are exclusively being developed and validated to be used in drug development, and used to support approval of drug products.
Biomarkers are mainly classified into Protein biomarkers, Nucleic acid based biomarkers, Lipid biomarkers and Small molecule biomarkers. Almost every pharmaceutical company has been developing biomarker programs. There has been a rapid increase in the number of Biomarkers Congress used in drug delivery over the last decade.

Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

Related  Conferences: 8th Biomarkers Conference, December 05-07, 2016 Philadelphia, USA; Biomarkers & Immuno-Oncology World Congress May 2-4,2017, Philadelphia, PA, 9th Genomics Conference, July 13-14, 2017, Chicago, USA; 9thPharmacogenomics Conference, July 13-14, 2017, Chicago, USA; 7th Proteomics Conference, October 24-26, 2016, Rome, Italy; 19th World Cancer Conference, November 21-23, 2017, London, UK; 12th Annual Biomarkers Congress February 21-24, 2017, Manchester, UK; 13th Annual Biomarkers & Diagnostics World Congress May 2-4, 2017, Philadelphia, USA; 2nd Biomarkers Conference February 06-07, 2017, San-Diego, USA; 19th International Conference on Biomarkers and Clinical Medicine, May 18-19, 2017, Paris, France; American Association for Cancer Research Annual Meeting April 01-05, 2017, Washington DC, USA; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark.

Europe Cancer Associations:

 European Cancer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European Cancer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition | European Network of Cancer Registries   | European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer| European Society of Gynaecological Oncology | European Society 

Track 2: Molecular Biomarkers

A cancer biomarker is an element or procedure that indicates the presence of cancer in the body. A biomarker may be any molecule released by presence a tumor or a specific indication of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease.Cancer biomarkers can be classified into Nucleic acid based biomarkers, Pathological biomarkers, In silico biomarkers, Imaging biomarkers and Glycoprotein biomarkers based on their structure and functioning. All these topics are discussed in these cancer biomarker conferences.

Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

Related Conferences: 2nd Cancer Diagnostics Conference, May 8-10, 2017, Barcelona, Spain; 6th Mass Spectrometry Conference, September 25-27, 2017, Atlanta, USA; 5th Mass Spectrometry Conference, December 12-14, 2017, Kuala Lumpur, Malaysia; 5th Medicinal Chemistry Conference, December 05-07, 2016, Phoenix, USA; 5th Computer Aided Drug Designing Conference, December 05-07, 2016, Phoenix, USA; 4th International Oncology Conference, September 29-30, 2016, Abu Dhabi, UAE; 8th UAE Cancer Congress, October 20-22, 2016, Dubai, UAE; American Thoracic Society Conference, May 19-24, 2017, Washington DC, USA; 17th World Conference on Lung Cancer December, 04-07, 2016 Austria; 5th Emirates Oncology Conference, November 17-19, 2016, Abu Dhabi, UAE; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; ASCO Annual Meeting, June 02-06, 2016, Chicago, USA; 25th AICR Research Conference, November 14-16, 2016, North Bethesda, USA.

Europe Cancer Associations:

European CanCer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European CanCer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition | European Network of Cancer Registries   | European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer| European Society of Gynaecological Oncology | European Society 

Track 3: Clinical biomarkers

Biomarkers which are used for clinical purposes are called clinical biomarkers. Clinical biomarkers along with provide a vibrant and influential methodology to understanding the range of many diseases with uses in judgemental and  analytic epidemiology, arbitrary clinical trials, screening for drugs or disease diagnosis and prognosis. Defined as changes in the constituents of cells or body fluids, these clinical biomarkers offer the means for standardized classification of a disease and risk factors, and the can extend the base information about the underlying pathogenesis of disease.The main researches in clinical biomarkers are done in the fields of drug discovery, oncology, pharmacogenomics  and disease diagnostics. 

 Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

Related Conferences: 3rd Biologic Drugs Conference, June 19-21, 2017 Philadelphia, USA; 3rd Genetic Engineering Conference, October 30-November 1, 2017, Las Vegas, USA; 3rd Protein Engineering Conference, October 30-November 1, 2017, Las Vegas, USA; 7th Personalized Medicine Conference, October 23-25, 2017 Chicago, USA; 7th Molecular Diagnostics Conference, October 23-25, 2017 Chicago, USA; Philippine Cancer Society;  European Organisation for Research and Treatment of Cancer;  American Society of Clinical Oncology; 5th Emirates Oncology Conference, November 17-19, 2016, Abu Dhabi, UAE; American Academy of Neurology Annual Meeting April 22-28, 2017, Boston, USA;  4th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA; 3rdAnnual Drug Discovery USA Congress, 3-4 October 2016, San Diego, USA.https://biomarkers.insightconferences.com/

Europe Cancer Associations:

European CanCer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European CanCer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition | European Network of Cancer Registries   | European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer| European Society of Gynaecological Oncology | European Society 

Track 4: Biomarkers and Cancers

Biomarkers play a significant role in cancer prognosis, diagnosis and treatment of cancers these days. There are many types of cancers which are hard to even diagnose. The latest designed biomarkers and their applications provide a great advantage in these cases. Cancer Epidemiology, treatment and latest research is greatly relayed on the biomarkers.
The major types of cancers in which biomarkers are widely being used are breast cancer, lung cancer, prostate cancer and blood cancer. Cancer biomarkers conferences provide a good platform for elaborated discussion on various new researches.

Biomarkers Conferences | Cancer Biomarkers Conferences  | Molecular Biomarkers Conferences

Related Conferences: Biomarkers & Immuno-Oncology World Congress May 2-4,2017, Philadelphia, PA, Medical Imaging Conference, October 20-21, 2016 Chicago, USA; 6th Radiology Conference, October 19-20, 2017, New York, USA; 6th Imaging Conference, October 19-20, 2017, New York, USA; 5th Euro-Global Experts Meeting on Medical Case Reports, September 7-9, 2017, Paris, France; 4th Clinical Case Reports Meeting, April 17-19, 2017, Dubai, UAE; 25th AICR Research Conference, November 14-16, 2016, North Bethesda, USA; National Cancer Institute;  Philippine Cancer Society;  European Organisation for Research and Treatment of Cancer; 5th Emirates Oncology Conference, November 17-19, 2016, Abu Dhabi, UAE; American Academy of Neurology Annual Meeting April 22-28, 2017, Boston, USA;  4th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA; 3rd Annual Drug Discovery USA Congress, 3-4 October 2016, San Diego, USA.

Europe Cancer Associations:

European CanCer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European CanCer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition | European Network of Cancer Registries   | European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer| European Society of Gynaecological Oncology | European Society 

Track 5: Biomarkers and Non-cancerous diseases

Biomarkers plan an important role in various neurological and cardiovascular diseases. The diseases which are incurable from ages are being offered a possible treatment and easy diagnosis with the help of advancements in biomarkers through different diagnostics and imaging technologies. Cardiac biomarkers and neuro biomarkers has brought a great revolution in disease diagnosis and prognosis. Biomarkers are used in many other non-cancerous diseases. Some of the important ones are Alzheimer’s disease, Neurodegenerative diseases, cardiovascular diseases, and Huntington's disease. 

Biomarkers Conferences  | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

Related Conferences: 6th Experts Meeting on Medical Case Reports, October 16-18, 2017, San Francisco, USA; 4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 15th World Angiology Meeting, December 08-09, 2016 Philadelphia, USA; 14th Clinical Cardiology Conference, November 14-16, 2016, Orlando, USA; 14th Experimental Cardiology Conference, November 14-16, 2016, Orlando, USA; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; ASCO Annual Meeting, June 02-06, 2016, Chicago, USA; 8th UAE Cancer Congress, October 20-22, 2016, Dubai, UAE; American Thoracic Society Conference, May 19-24, 2017, Washington DC, USA; 17th World Conference on Lung Cancer December, 04-07, 2016 Austria; 5th Emirates Oncology Conference, November 17-19, 2016, Abu Dhabi, UAE; American Academy of Neurology Annual Meeting April 22-28, 2017, Boston, USA.

Europe Cancer Associations:

European CanCer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European CanCer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition | European Network of Cancer Registries   | European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer| European Society of Gynaecological Oncology | European Society 

Track 6:  Biomarkers Detection & Discovery

Biomarker discovery requires highly assured identification of a biomarker with real-time quantitative information to indicate which proteins are altering to a statistically pertinent degree in response to disease. The discovery of  biomarkers has developed new strategies starting from the initial steps. In the first stage of biomarker discovery proceedings, investigation depends upon mass spectrometry techniques to make unbiased, semiquantitative analysis of changes between healthy and diseased states. The slope of probable biomarkers generated in the discovery stage is to be further substantiated due to the high false positive rate. It is done through supplemental more targeted and quantitative mass spectrometry techniques, such as immuno affinity peptide enrichment.

Under this track, the latest trends in discovery and development of biomarkers and biomarker identification are discussed. There are many new strategies being fashioned in development of biomarkers. In this section advancements of biomarkers in various sectors like clinical biomarkers, paediatric diseases biomarkers, and clinical analysis of NGS samples are covered.

 Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

 Related Conferences 4th Clinical Case Reports Meeting, April 17-19, 2017, Dubai, UAE; 6th Imaging Conference, October 19-20, 2017, New York, USA; Medical Imaging Conference, October 20-21, 2016 Chicago, USA; 5th Translational Medicine Conference, November 28-30, 2016, San Francisco, USA; 14th Global Experts Meeting on Nanomaterials, March 30- 31, 2017, Madrid, Spain; 7th Personalized Medicine Conference, October 23-25, 2017 Chicago, USA; Association for International Cancer Research; Philippine Cancer Society; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; 13th Annual Biomarkers & Diagnostics World Congress May 2-4, 2017, Philadelphia, USA; 4th International Oncology Conference, September 29-30, 2016, Abu Dhabi, UAE; 5th Emirates Oncology Conference, November 17-19, 2016, Abu Dhabi, UAE;  4th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Next Generation Dx Summit, August 15-18, 2017, Washington DC, USA.

Europe Cancer Associations:

European CanCer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European CanCer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition | European Network of Cancer Registries   | European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer| European Society of Gynaecological Oncology | European Society 

Track 7: Advances of Biomarker testing

Biomarker testing is a group of tests that looks for the molecular signs of health so that doctors can plan the best care. Biomarker testing can also be called as genetic testing or biomarkers testing.  Biomarkers, a foundation of precision oncology, are very important in management of breast cancer, gastro-esophageal cancer and non-small cell lung cancer. Testing practices are intensely deliberated, influencing diagnostic quality and affecting pathologists, oncologists and patients.

The advances in biomarker testing are mainly in the fields of genetic testing, cancers and other diseases in their diagnosis, treatment and imaging. In silico biomarkers, microRNA biomarkers and several other clinical biomarkers evolved in the recent researches have opened up the path for biomarker testing broader.

Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

Related Conferences:  6th Mass Spectrometry Conference, September 25-27, 2017, Atlanta, USA; 14th Clinical Cardiology Conference, November 14-16, 2016, Orlando, USA; Molecular Cardiology Conference, August 31- September 1, 2017, Philadelphia, USA; 3rd Pediatric Cardiology Conference, September 25-27, 2017, Chicago, USA; 11th World Neurology Congress, March 27-29, 2017, Madrid, Spain; European Organisation for Research and Treatment of Cancer; American Association for Cancer Research Annual Meeting April 01-05, 2017, Washington DC, USA; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; 2nd Biomarkers Conference February 06-07, 2017, San-Diego, USA; 4th International Oncology Conference, September 29-30, 2016, Abu Dhabi, UAE; 17th World Conference on Lung Cancer December, 04-07, 2016 Austria;  4th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA.

Europe Cancer Associations:

European Cancer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European Cancer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition 

Track 8:  Exosomes

Exosomes are  released from the cell when multi vesicular bodies fuse with the plasma membrane . Exosomes have specialized functions and play a key role in processes such as coagulation, intercellular signalling, and waste management. They are being recognized as potential therapeutics as they have the ability to elicit potent cellular responses in vitro and in vivo. Compared with biomarkers identified in conventional specimens such as serum or urine, exosomal biomarkersprovide the highest amount of sensitivity and specificity, which can be attributed to their excellent stability. The molecular constituents of exosomes, especially exosomal proteins and microRNAs (miRNAs), are promising as biomarkers in clinical diagnosis.

Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

Related Conferences:  6th Mass Spectrometry Conference, September 25-27, 2017, Atlanta, USA; 14th Clinical Cardiology Conference, November 14-16, 2016, Orlando, USA; Molecular Cardiology Conference, August 31- September 1, 2017, Philadelphia, USA; 3rd Pediatric Cardiology Conference, September 25-27, 2017, Chicago, USA; 11th World Neurology Congress, March 27-29, 2017, Madrid, Spain; European Organisation for Research and Treatment of Cancer; American Association for Cancer Research Annual Meeting April 01-05, 2017, Washington DC, USA; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; 2nd Biomarkers Conference February 06-07, 2017, San-Diego, USA; 4th International Oncology Conference, September 29-30, 2016, Abu Dhabi, UAE; 17th World Conference on Lung Cancer December, 04-07, 2016 Austria;  4th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA.

Europe Cancer Associations:

European Cancer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European Cancer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition 

Track 9: Emerging  Therapeutic Biomarkers

A reliable Therapeutic biomarker would facilitate the individualization of current management algorithms, ensure that pathogenic mechanisms were disrupted or eliminated prior to treatment withdrawal, and reduce the frequency of relapse or unnecessary protracted therapy.Hence there are various researches in progress to discover new Biomarkers for various disease starting from autoimmune disorders to cardiovascular and Genetic disorders.

Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

Related Conferences:  6th Mass Spectrometry Conference, September 25-27, 2017, Atlanta, USA; 14th Clinical Cardiology Conference, November 14-16, 2016, Orlando, USA; Molecular Cardiology Conference, August 31- September 1, 2017, Philadelphia, USA; 3rd Pediatric Cardiology Conference, September 25-27, 2017, Chicago, USA; 11th World Neurology Congress, March 27-29, 2017, Madrid, Spain; European Organisation for Research and Treatment of Cancer; American Association for Cancer Research Annual Meeting April 01-05, 2017, Washington DC, USA; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; 2nd Biomarkers Conference February 06-07, 2017, San-Diego, USA; 4th International Oncology Conference, September 29-30, 2016, Abu Dhabi, UAE; 17th World Conference on Lung Cancer December, 04-07, 2016 Austria;  4th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA.

Europe Cancer Associations:

European Cancer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European Cancer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition 

Track 10: Digital Biomarkers

Digital Biomarkers are changing the face of Clinical trials. Digital Biomarkers will at a minimum,face the same regulatory challenges as traditional Biomarkers.There is a great potential to apply Digital Biomarkers to medical domains that are not very well understood such as pyschiatry and neurology. They can be used to explain ,influence and or predict health related outcomes.

Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

Related Conferences:  6th Mass Spectrometry Conference, September 25-27, 2017, Atlanta, USA; 14th Clinical Cardiology Conference, November 14-16, 2016, Orlando, USA; Molecular Cardiology Conference, August 31- September 1, 2017, Philadelphia, USA; 3rd Pediatric Cardiology Conference, September 25-27, 2017, Chicago, USA; 11th World Neurology Congress, March 27-29, 2017, Madrid, Spain; European Organisation for Research and Treatment of Cancer; American Association for Cancer Research Annual Meeting April 01-05, 2017, Washington DC, USA; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; 2nd Biomarkers Conference February 06-07, 2017, San-Diego, USA; 4th International Oncology Conference, September 29-30, 2016, Abu Dhabi, UAE; 17th World Conference on Lung Cancer December, 04-07, 2016 Austria;  4th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA.

Europe Cancer Associations:

European Cancer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European Cancer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition 

Track 11: Biomarkers and Personalized medicine

Biomarkers are of increasingly high importance in medicine, particularly in the realm of 'personalized medicine'. They are valuable for predicting prognosis and dose selection. Moreover, they may be helpful in detecting therapeutic and adverse responses and in patient stratification based on efficacy or safety prediction. Thus, biomarkers are essential tools for the selection of appropriate patients for treatment with certain drugs to and enable personalized medicine, that is 'providing the right treatment to the right patient, at the right dose at the right time'. Prognostic biomarkers are of particular significance for malignant conditions. Similarly, Diagnostic biomarkers are important in autoimmune diseases. Disease severity biomarkers are helpful tools in the treatment for inflammatory skin diseases. Identification, qualification and implementation of the different kinds of biomarkers are challenging and frequently necessitate collaborative efforts.

Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences

Related  Conferences: 8th Biomarkers Conference, December 05-07, 2016 Philadelphia, USA; Biomarkers & Immuno-Oncology World Congress May 2-4,2017, Philadelphia, PA, 9th Genomics Conference, July 13-14, 2017, Chicago, USA; 9thPharmacogenomics Conference, July 13-14, 2017, Chicago, USA; 7th Proteomics Conference, October 24-26, 2016, Rome, Italy; 19th World Cancer Conference, November 21-23, 2017, London, UK; 12th Annual Biomarkers Congress February 21-24, 2017, Manchester, UK; 13th Annual Biomarkers & Diagnostics World Congress May 2-4, 2017, Philadelphia, USA; 2nd Biomarkers Conference February 06-07, 2017, San-Diego, USA; 19th International Conference on Biomarkers and Clinical Medicine, May 18-19, 2017, Paris, France; American Association for Cancer Research Annual Meeting April 01-05, 2017, Washington DC, USA; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark.

Europe Cancer Associations:

European Cancer Organisation: ECCO | ESMO: European Society for Medical Oncology | European Association for Cancer Research  |European Cancer Organisation | European Organisation for Research and Treatment of Cancer | European Prostate Cancer Coalition | European Society of Breast Cancer Specialists | Federation of European Cancer Societies | European Society for Pediatric Oncology – SIOPE | European Academy of Cancer Sciences | European School of Oncology  | Organization of European Cancer Institute | European Breast Cancer Coalition 

Past Conference Report

World Biomarkers 2017

9^th World Biomarkers Congress was recently held during December 07-08, 2017 at Madrid, Spain.

World Biomarkers 2017 have taken up the scientific thoughts towards proving the importance of accurate diagnostics to be prevital towards the curing efficacy. The scientific meeting has laid path for the designing and development of research methodologies with the theme impact of “A New Era of Diagnosis and Clinical Research”. The discovery significance of the curative approach could be validated with the effectiveness of the associated clinical trials. Considering the technical integracy the Biomarkers conference embodied the research area of clinical trials and invited biopharma healthcare players. This integrated participation helped and will facilitate the technology transfer towards the recognition of biomolecular set in the form of either the specific molecule or the effective molecular pathway. The conference has tried grounding every aspect related to the Biomarkers Discovery covering the possible research areas.

This conference brought together Leading Clinical Researchers, Oncologists, Cancer Researchers, Professors, Pharmaceutical Companies, Diagnostics Companies, Students and other professionals in which many issues in Oncology & Cancer field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for networking.

The program highlights of the meeting were the eponymous lectures

·         Jianhua Luo, University of Pittsburgh, USA

·         Topolcan Ondrej, Charles University, Czech Republic

·         Wancai Yang, University of Illinois at Chicago, USA

·         Ashleigh McConnell, AMLo Biosciences Limited

Poster Evaluation Committee and the Winner:

World Biomarkers 2017 would like to acknowledge Dr.Topolcan Ondrej for his evaluation of the poster session and we are glad to congratulate Ms. Rocío Thompson-Bonilla, for receiving the Best Poster Award of the conference.

Conference series llc LTD takes its pleasure to thank all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and all who supported the conference in every aspect for the magnificent presence at the venue.

Conference Series llc LTD is overwhelmed to announce the commencement of its 13th World Biomarkers Conference on November 29-30, 2018 at Dublin, Ireland.

For More details visit: https://biomarkers.insightconferences.com/

 We hope to see u soon with us at World Biomarkers 2018